Compound Detail
CHEMBL558459
HYDRAZOBENZENE Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL558459 |
| Name | HYDRAZOBENZENE |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | YBQZXXMEJHZYMB-UHFFFAOYSA-N |
2
Targets
4
Activities
1
Assay Types
0
PK Parameters
5
Publications
0
Known Names
Molecular Properties
184.2
MW (Da)
3.13
ALogP
2
HBA
2
HBD
24.1
PSA (Ų)
0.72
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 6.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Cathepsin D CHEMBL2581 | IC50 | 6.0 | 5.81 | 1000.0 | 2 |
| Plasmepsin II CHEMBL4414 | IC50 | 6.0 | 5.99 | 1000.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Plasmepsin II | IC50 | = | 1000.0 | nM | 6.0 | Inhibition of Plasmodium falciparum plasmepsin 2 using DABCYL-Glu-Arg-Nle-Phe-Le... | 31062983 |
| Cathepsin D | IC50 | = | 1000.0 | nM | 6.0 | Inhibition of human liver cathepsin D using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-P... | 31062983 |
| Plasmepsin II | IC50 | = | 1050.0 | nM | 5.98 | Inhibition of recombinant Plasmodium falciparum Plasmepsin 2 | 31913032 |
| Cathepsin D | IC50 | = | 2400.0 | nM | 5.62 | Inhibition of human cathepsin D | 31913032 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 19272677 | 10.1016/j.ejmech.2009.02.014 | Mus musculus | 1 |
| 31062983 | 10.1021/acs.jmedchem.9b00184 | Plasmepsin II | 1 |
| 31062983 | 10.1021/acs.jmedchem.9b00184 | Cathepsin D | 1 |
| 31913032 | 10.1021/acs.jmedchem.9b01622 | Plasmepsin II | 1 |
| 31913032 | 10.1021/acs.jmedchem.9b01622 | Cathepsin D | 1 |
Data from ChEMBL 36 via Core Engine